Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D04PMQ
|
||||
Former ID |
DNCL003353
|
||||
Drug Name |
Brilinta/Brilique
|
||||
Synonyms |
EUCLID
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Arterial thrombosis; Myocardial infarction [ICD9: 437.6, 453, 671.5, 671.9, 410; ICD10:I80-I82, I21, I22] | Phase 3 | [524133] | ||
Company |
AstraZeneca
|
||||
Structure |
Download2D MOL |
||||
Formula |
C23H28F2N6O4S
|
||||
Canonical SMILES |
CCCSC1=NC2=C(C(=N1)NC3CC3C4=CC(=C(C=C4)F)F)N=NN2C5CC(C(<br />C5O)O)OCCO
|
||||
InChI |
1S/C23H28F2N6O4S/c1-2-7-36-23-27-21(26-15-9-12(15)11-3-4-13(24)14(25)8-11)18-22(28-23)31(30-29-18)16-10-17(35-6-5-32)20(34)19(16)33/h3-4,8,12,15-17,19-20,32-34H,2,5-7,9-10H2,1H3,(H,26,27,28)/t12-,15+,16+,17-,19-,20+/m0/s1
|
||||
InChIKey |
OEKWJQXRCDYSHL-FNOIDJSQSA-N
|
||||
PubChem Compound ID | |||||
PubChem Substance ID |
14836432, 14860737, 24162024, 45293678, 49684205, 57373617, 77877844, 92729712, 96025700, 103554312, 123051091, 124759706, 126644885, 126666051, 135649975, 136345665, 137171656, 139857160, 152040158, 152258075, 160645837, 160646914, 162011636, 163346229, 163383616, 164178089, 164765598, 165245536, 170501033, 171063069, 172914585, 174528632, 175267325, 175427101, 185974765, 189657701, 198993342, 211534943, 223384813, 223666650, 224638556, 228139491, 247988848, 249582784, 249807649, 249807650, 249816423, 251966736, 251970939, 252216468
|
||||
Target and Pathway | |||||
Target(s) | P2Y purinoceptor 12 | Target Info | Modulator | [543771] | |
KEGG Pathway | Platelet activation | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.